AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
Jul 042013
 

 

Sarepta Therapeutics Announces At-the-Market Equity Offering Facility
Wall Street Journal
for general corporate purposes, including for manufacturing scale up for eteplirsen, the planned confirmatory Phase III clinical study of eteplirsen and early development activities related to follow-on Duchenne muscular dystrophy drugs and other

 

READ AT

http://online.wsj.com/article/PR-CO-20130703-908304.html

 

Share

Sorry, the comment form is closed at this time.

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: